Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

10

Number of overlapping holdings

33.3%

% of MEDX's 30 holdings also in PPH

41.7%

% of PPH's 27 holdings also in MEDX

Overlap by Weight
Sector Drift (MEDX minus PPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in PPH
Overlap
ELI LILLY & CO 15.1% 11.7% 11.7%
ASTRAZENECA PLC-SPONS ADR 5.7% 5.9% 5.7%
ABBVIE INC 7.3% 5.4% 5.4%
MERCK & CO. INC. 5.2% 6.2% 5.2%
NOVARTIS AG-ADR 5.8% 5.0% 5.0%

Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PPH
AMGEN INC 6.1%
REGENERON PHARMACEUTICALS 4.1%
BIOGEN IDEC INC 4.1%
ELI LILLY & CO 3.4%
ALKERMES PLC 3.3%
CRISPR THERAPEUTICS AG 3.2%
IONIS PHARMACEUTICALS, INC. 2.9%
ALNYLAM PHARMACEUTICALS INC 2.6%
INTELLIA THERAPEUTICS, INC. 2.1%
ABBVIE INC 1.8%
MEDX Underweight Relative to PPH
NOVO-NORDISK A/S-SPONS ADR -9.6%
MCKESSON CORP -4.8%
SANOFI-AVENTIS-ADR -4.7%
AMERISOURCEBERGEN CORP -4.3%
ZOETIS INC -4.2%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS -4.1%
TEVA PHARMACEUTICAL-SP ADR -3.3%
JOHNSON & JOHNSON -1.9%
GLAXOSMITHKLINE PLC-SPON ADR -1.8%
VIATRIS, INC. -1.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY